by admin | Dec 8, 2022 | News & Opinions
By Penn Today Penn Medicine researchers laud the early results for CAR T therapy in lupus patients, which point to broader horizons for the use of personalized cellular therapies. Engineered immune cells, known as CAR T cells, have shown the world what personalized...
by admin | Dec 7, 2022 | News & Opinions
by Rameesha Sajwar – Wonderful Engineering Gene-editing technology CRISPR has been used to remove genes from immune system cells to make them better at fighting cancer. Recently, PACT Pharma and UCLA have used CRISPR to remove and add genes to these cells to...
by admin | Dec 6, 2022 | News & Opinions
CIRM-funded USC+CHLA Alpha Clinic boosts capacity for clinical and translational research, community outreach, training and manufacturing By Wayne Lewis – Keck School of Medicine of USC The California Institute for Regenerative Medicine (CIRM), the state’s stem...
by admin | Dec 5, 2022 | News & Opinions
by Kelsey A. Rankin, Alison Mosier-Mills, Walter Hsiang & Daniel H. Wiznia – BMC Archives of Public Health Abstract Secret shopper studies are particularly potent study designs that allow for the gathering of objective data for a variety of research...
by admin | Dec 1, 2022 | News & Opinions
by by Kerstin Wagner, Leibniz-Institut für Alternsforschung – Fritz-Lipmann-Institut e.V. (FLI) – Phys.org Image: Hematopoietic stem cells age very heterogeneously. The TAZ protein, a co-activator of the Hippo signaling pathway, can protect blood stem...
